factor

(redirected from factor II)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to factor II: factor IIa

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
References in periodicals archive ?
The expression and role of insulin-like growth factor II in malignant hemangiopericytomas.
Univariate F-test analysis of the group means indicated that significant differences exist for Factor I (Employer Development), Factor II (Vocational Exploration), Factor III (Basic Placement Activities), and Factor IV (Multi System Facilitation) and one or more of the employment settings at the .
Factor II, Supervision Competence, involves the ability of the nurse graduate to coordinate implementation of a plan of nursing care by ancillary or subordinate members of the health care team who are responsible for specific aspects of the plan.
Investigators screened for three mutations--factor V Leiden, factor II, and methylenetetrahydrofolate reductase (MTHFR)--in 103 women with complicated pregnancies and 223 controls with uncomplicated pregnancies.
Factor I consists of 15 items concerning the Appropriateness of Competitive Employment; Factor II consists of 7 items focused on the Disadvantages of Competitive Employment With a Focus on Others.
6336/14 factor ii, factor ix, factor vii, factor x powder and solution for parenteral use, road 500 iu
5 min indicates the need for factor V Leiden genotyping, whereas a peak thrombin concentration >433 nmol/L indicates the need for factor II G20210A genotyping.
In addition to factor II and V variants, variants have been discovered similarly in genes coding for MTHFR and HFE (3, 4).
Contract awarded for factor ii, factor ix, factor vii, factor x powder & solution for parenteral use, road 500 iu
Food and Drug Administration (FDA) has granted 510(k) market clearance for the VeraCode[R] Genotyping Test for Factor V (Leiden) and Factor II (Prothrombin).
The aim of our work was to establish a multiplex protocol for direct pyrosequencing analysis of a panel of coagulation factors mutations: the 3 single-nucleotide polymorphisms (SNPs) most commonly associated with thrombophilia--G1691A in factor V Leiden, G20210A in factor II, and C677T in methylenetetrahydrofolate reductase (MTHFR)--for a first-tier screening, and 3 additional polymorphisms--A1298C in MTHFR, Val34Leu in factor XIII, and 4G/5G in plasminogen activator inhibitor-1 (PAI-1)--which are believed not to have an independent effect on venous thrombosis but could be investigated in a second-tier screening because they may act synergistically with the previously mentioned factor mutations (16,17) or, in the case of factor XIII Val34Leu, exert a protective effect (18).